Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia

AIM To stratify the malignancy risks in thyroid nodules in a tertiary care referral center using the Bethesda system. METHODS From January, 2012 to December, 2014, a retrospective analysis was performed among 1188 patients (15-90 years) who had 1433 thyroid nodules and fine-needle aspiration at Prince Sultan Military Medical City, Saudi Arabia. All thyroid cyto-pathological slides and ultra sound reports were reviewed and classified according to the Bethesda System for Reporting Thyroid Cytopathology. Age, gender, cytological features and histological types of the thyroid cancer were collected from patients’ medical chart and cytopathology reports. RESULTS There were 124 total cases of malignancy on resection, giving an overall surgical yield malignancy of 33.6%. Majority of the thyroid cancer nodules (n = 57, 46%) in Bethesda VI category followed by Bethesda IV (n = 25, 20.2%). Almost 40% of the cancer nodules in 31-45 age group in both sex. Papillary thyroid carcinoma (PTC) was the most common form of thyroid cancer among the study population (111, 89.6%) followed by 8.9% of follicular thyroid carcinoma (FTC), 0.8% of medullary carcinoma and 0.8% of anaplastic carcinoma. Among the Bethesda IV category 68% thyroid nodules were PTC and 32% FTC. CONCLUSION The malignancy values reported in our research were constant and comparable with the results of other published data with respect to the risk of malignancy. Patients with follicular neoplasm/suspicious for follicular neoplasm and suspicious of malignancy categories, total thyroidectomy is indicted because of the substantial risk of malignancy.

[1]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[2]  A. Gawande,et al.  Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. , 2016, Thyroid : official journal of the American Thyroid Association.

[3]  F. C. Holsinger,et al.  Thyroid and Parathyroid Cancers , 2016 .

[4]  Juan Rosai,et al.  Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference , 2008, Diagnostic cytopathology.

[5]  E. Mazzaferri,et al.  Thyroid cancer in thyroid nodules: finding a needle in the haystack. , 1992, The American journal of medicine.

[6]  A. Al-Zahrani,et al.  Epidemiology of thyroid cancer: a review with special reference to Gulf Cooperation Council (GCC) states. , 2007, The Gulf journal of oncology.

[7]  L. Mazzucchelli,et al.  Comparison of 5‐tiered and 6‐tiered diagnostic systems for the reporting of thyroid cytopathology , 2012, Cancer cytopathology.

[8]  D. O’Connell,et al.  Predictors of non-diagnostic cytology in surgeon-performed ultrasound guided fine needle aspiration of thyroid nodules , 2014, Journal of Otolaryngology - Head & Neck Surgery.

[9]  E. Cibas Fine-needle aspiration in the work-up of thyroid nodules. , 2010, Otolaryngologic clinics of North America.

[10]  P DESAIVE,et al.  [Thyroid cancer]. , 1951, Revue medicale de Liege.

[11]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[12]  Eva Negri,et al.  Thyroid cancer mortality and incidence: A global overview , 2015, International journal of cancer.

[13]  R. Pazdur,et al.  Cancer Management: A Multidisciplinary Approach , 2007 .

[14]  N. Ezzat,et al.  Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. , 2012, Journal of the Egyptian National Cancer Institute.

[15]  T. Elsheikh,et al.  The Bethesda system for reporting thyroid cytopathology: An experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy , 2012, Diagnostic cytopathology.

[16]  E. Negri,et al.  Thyroid cancer pooled analysis from 14 case–control studies: what have we learned? , 2003, Cancer Causes & Control.

[17]  M. Milas,et al.  Diagnostic Accuracy of Surgeon-Performed Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules , 2011, Annals of Surgical Oncology.

[18]  S. Jung,et al.  Application of Bethesda System for Reporting Thyroid Aspiration Cytology , 2010 .

[19]  S. Almalki,et al.  The Incidence Rate of Thyroid Cancer Among Women in Saudi Arabia: An Observational Descriptive Epidemiological Analysis of Data from Saudi Cancer Registry 2001–2008 , 2015, Journal of Immigrant and Minority Health.

[20]  E. Son,et al.  Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience , 2014, Korean journal of pathology.

[21]  R. Udelsman,et al.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. , 2009, Thyroid : official journal of the American Thyroid Association.

[22]  J. Panayiotides,et al.  The role of liquid‐based cytology in the investigation of thyroid lesions , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[23]  S. Mondal,et al.  The Bethesda system for reporting thyroid fine needle aspirates: A cytologic study with histologic follow-up , 2013, Journal of cytology.

[24]  Martha Pitman,et al.  Thyroid fine-needle aspiration biopsy: variability in reporting. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  E. Stelow,et al.  Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. , 2010, American journal of clinical pathology.

[26]  M. Sobrinho-Simões,et al.  Follicular thyroid carcinoma , 2011, Modern Pathology.

[27]  L. Mazzucchelli,et al.  The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis , 2012, Acta Cytologica.

[28]  S. Mufti,et al.  The bethesda system for reporting thyroid cytopathology: a five-year retrospective review of one center experience. , 2012, International journal of health sciences.

[29]  O. Clark,et al.  Papillary thyroid cancer , 2006, Current treatment options in oncology.

[30]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[31]  Asli Muratli,et al.  Diagnostic efficacy and importance of fine-needle aspiration cytology of thyroid nodules , 2014, Journal of cytology.

[32]  B. Yoder,et al.  Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. , 2006, Thyroid : official journal of the American Thyroid Association.

[33]  F. Hajmanoochehri,et al.  FNAC accuracy in diagnosis of thyroid neoplasms considering all diagnostic categories of the Bethesda reporting system: A single-institute experience , 2015, Journal of cytology.

[34]  S. Kala,et al.  Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology , 2016, Journal of cytology.

[35]  N. Chaudhri,et al.  Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. , 2013, Hematology/oncology and stem cell therapy.

[36]  P. Arul,et al.  A correlative study of solitary thyroid nodules using the bethesda system for reporting thyroid cytopathology. , 2015, Journal of cancer research and therapeutics.